Singapore, April 15 -- Nanoform Finland Plc has announced a strategic partnership whereby CBC Co. will utilise its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoform's cutting-edge nanomedicine engineering technologies.

Nanoformed medicines have been shown to overcome innovators' drug bioavailability issues and reduce dose size and pill burden to improve patient-acceptance, both for new drugs and reformulations of existing products.

"This strategic partnership with CBC represents a significant milestone in our ongoing effort to bring our cutting-edge nanotechnology to enable improved medicines for patients around the world. Japan is a key country for innovative drug development, and we ar...